Phenylketonuria: Findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment

Radiology

Volumn 201, Issue 2, 1996, Pages 413-420

  Pietz, Joachim ^a   Kreis, Roland ^b   Schmidt, Hildgund ^a   Meyding Lamadé, Uta K ^a   Rupp, André ^a   Boesch, Chris ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Brain, MR; Brain, white matter; Magnetic resonance (MR), spectroscopy; Phenylketonuria

Indexed keywords

PHENYLALANINE; PROTON;

ADOLESCENT; ADULT; ARTICLE; BRAIN METABOLISM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENYLKETONURIA; PRIORITY JOURNAL;

EID: 0029954988     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.201.2.8888233     Document Type: Article

References (33)

1. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylalaninaemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill, 1995; 1015-1075.
2. Azen CG, Koch R, Friedman EG, et al. Intellectual development in 12-year-old children treated for phenylketunuria. Am J Dis Child 1991; 5:35-39.
3. Pietz J, Schmidt E, Matthis P, Kobialka B, Kutscha A, de Sonneville L. EEGs in phenylketonuria: I. follow-up to adulthood; II. short-term diet-related changes in EEGs and cognitive function. Dev Med Child Neurol 1993; 35:54-64.
4. Pearsen KD, Gean-Marton AD, Levy HL, Davis KR. Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 1990; 177:437-440.
5. Bick U, Fahrendorf G, Ludolph AC, Vassallo P, Weglage J, Ullrich K. Disturbed myelination in patients with hyperphenylalaninaemia: evaluation with magnetic resonance imaging. Eur J Pediatr 1991; 150: 185-189.
6. Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP. Brain MRI changes in phenylketonuria: associations with dietary status. Brain 1993; 116:811-821.
7. Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging of the brain in phenylketonuria. Lancet 1994; 344:87-90.
8. Hennig J, Pfister H, Ernst T, Ott D. Direct absolute quantification of metabolites in the human brain with in vivo proton spectroscopy. NMR Biomed 1992; 5:193-199.
9. Ernst T, Kreis R, Ross B. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson B 1993; 102:1-8.
10. Kreis R, Ernst T, Ross B. Absolute quantitation of water and metabolites in the human brain. II. Metabolites. J Magn Reson B 1993; 102:9-19.
11. Novotny EJ, Avison MJ, Herschkowitz N, et al. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy. Pediatr Res 1995; 37:244-249.
12. 1H magnetic resonance spectroscopy. J Magn Reson B 1995; 107:242-251.
13. 1H magnetic resonance spectroscopy. Pediatr Res 1995; 38:657-663.
14. De Sonneville LMJ. SVAT: a computer-based approach to development and disorders of information processing. In: Maarse FJ, Akkerman AE, Brand N, Mulder LJM, van der Stell M, eds. Computers in psychology: tools for experimental and applied psychology. Vol 4. Lisse, The Netherlands: Swets & Zeitlinger, 1993; 168-176.
15. Bottomley PA. PRESS sequence. U.S. patent 4,480,228, 1984.
16. Hennig J. The application of phase rotation for localized in vivo spectroscopy with short echo times. J Magn Reson 1992; 96: 40-49.
17. Kreis R, Fusch C, Maloca P, Felblinger J, Boesch C. Supposed pathology may be individuality: interindividual and regional differences of brain metabolite concentrations determined by 1H MRS (abstr). In: Proceedings of the Society of Magnetic Resonance 1994. Berkeley, Calif: Society of Magnetic Resonance, 1994; 45.
18. Villasana D, Butler IJ, Williams JC, Roongta SM. Neurological deterioration in adult phenylketonuria. J Inherit Metabol Dis 1989; 12:451-457.
19. Thompson AJ, Smith I, Brenton DP, et al. Neurological deterioration in young adults with phenylketonuria. Lancet 1990; 336: 602-605.
20. Pietz J, Meyding-Lamadé UK, Schmidt H. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Eur J Pediatr 1996; 155 (suppl 1):569-573.
21. Golomb J, Kluger A, Gianutsos J, Ferris SH, de Leon MJ, George AE. Nonspecific leukoencephalopathy associated with aging. Neuroimaging Clin North Am 1995; 5:33-44.
22. Bick U, Ullrich K, Stöber U, et al. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 1993; 152: 1012-1020.
23. Cleary MB, Walter JH, Wraith JE, White F, Tyler K, Jenkins JPR. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 1995; 127:251-255.
24. Uhlenbrock D, Seidel D, Gehlen W, et al. MR imaging in multiple sclerosis: comparison with clinical, CSF, and visual evoked potential findings. AJNR 1988; 9:59-67.
25. Walter JH, Tyfield LA, Holton JB, Johnson C. Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria. Eur J Pediatr 1993; 152:822-827.
26. Weglage J, Schuierer G, Kurlemann G, Ullrich K. Different degrees of white matter abnormalities in untreated phenylketonurics: findings in magnetic resonance imaging. J Inherit Metabol Dis 1993; 16:1047-1048.
27. Möller HE, Vermathen P, Ullrich K, Weglage J, Koch HG, Peters PE. In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment. Neuropediatrics 1995; 26:199-202.
28. Brand A, Richter Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15:289-298.
29. Lou HC, Toft PB, Andresen J, et al. An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia. J Inherit Metabol Dis 1992; 15: 687-695.
30. Hájek M, Hejcmanová L, Prádny J. Proton in vivo spectroscopy of patients with hyperphenylalaninaemia. Neuropediatrics 1993; 24:111-112.
31. Johannik K, Van Hecke P, Francois B, et al. Localized brain proton NMR spectroscopy in young adult phenylketonuria patients. Magn Reson Med 1994; 31:53-57.
32. Martin JJ, Schlote W. Central nervous system lesions in disorders of amino-acid metabolism: a neuropathological study. J Neurol Sci 1972; 15:49-76.
33. Hommes FA, Matsuo K. On a possible mechanism of abnormal brain development in experimental hyperphenylalaninemia. Neurochem Int 1987; 11:1-10.